
Olin Corporation Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violat...
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Olin Corporation ("Olin Corporation") (NYSE:OLN) concerning possib...

The Schall Law Firm Invites Shareholders With Losses In Olin Corporation To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Olin ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Olin Corporation. - OLN
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE:OLN). Such investors are advised to contac...

OLN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Olin Corporation Shareholders Who Lost Money
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Olin Corporation ("Olin Corporation") (NYSE:OLN) concerning possibl...

Olin (OLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Olin (OLN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree...

Olin (OLN) Q4 Earnings and Revenues Surpass Estimates
Olin (OLN) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.30 per share a year ago.

Swarm Oncology Unveils Highly Differentiated, Personalised T Cell Therapy Platform to Significantly Improve Treatment Outcome for Cancer Patients a...
London, U.K., January 27 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “the Company”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with adv...

Olin: Shares Are Cheap Even With Subdued Results (Rating Upgrade)
Olin Corporation shares fell 38% in 2024 due to weak Chinese demand and management turnover, creating a potential value opportunity for 2025. Despite ongoing challenges, new management's guidance a...
What Are the Rifles That Defined Combat During World War II?
While the main adversaries in World War II were the Allies and Axis powers, the fighting involved 70 nations around the world. Every continent saw fighting except for Antarctica. It’s hard to get a...

Olin Hosts 2024 Investor Day and Announces Increase in Share Repurchase Authorization to $2.0 Billion
CLAYTON, Mo. , Dec. 12, 2024 /PRNewswire/ -- Olin Corporation (NYSE: OLN) will host an Investor Day in New York City today, beginning at 9:00am (ET).

Reminder to Join Olin Corporation's Investor Day on December 12, 2024
CLAYTON, Mo. , Dec. 9, 2024 /PRNewswire/ -- As previously announced, Olin Corporation (NYSE: OLN) will host an Investor Day on Thursday, December 12 from 9:00am – 12:00pm (ET).

Olin's Q3 Earnings Miss, Revenues Surpass Estimates, Down Y/Y
The top line of OLN's chemical businesses in Q3 decrease due to Hurricane Beryl-related sales losses.

Olin: The U.S. Army Contracts And Epoxy Segment Improvements Make It Cheap
Olin Corp.'s strong business model, bolstered by U.S. Army contracts and decades of chemical industry know-how, suggests significant revenue growth potential through 2030. Derivative strategies, co...

Olin Corporation: Update For 2024E, A 'Buy' But With A Note
Olin Corporation has underperformed, with my stake down over 20%, but I still see long-term potential despite short-term challenges. 3Q24 results were impacted by Hurricane Beryl and weak Chlor Alk...

Olin (OLN) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Olin (OLN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar...
Related Companies